Di Paolo A - Search Results

1

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.

Allegrini G, Falcone A, Fioravanti A, Barletta MT, Orlandi P, Loupakis F, Cerri E, Masi G, Di Paolo A, Kerbel RS, Danesi R, Del Tacca M, Bocci G. Allegrini G, et al. Among authors: di paolo a. Br J Cancer. 2008 Apr 22;98(8):1312-9. doi: 10.1038/sj.bjc.6604311. Epub 2008 Mar 25. Br J Cancer. 2008. PMID: 18362940 Free PMC article.

2

MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery.

Costa M, Danesi R, Agen C, Di Paolo A, Basolo F, Del Bianchi S, Del Tacca M. Costa M, et al. Among authors: di paolo a. Cancer Res. 1994 Jan 1;54(1):9-11. Cancer Res. 1994. PMID: 7505201

3

Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice.

Innocenti F, Danesi R, Di Paolo A, Agen C, Nardini D, Bocci G, Del Tacca M. Innocenti F, et al. Among authors: di paolo a. Drug Metab Dispos. 1995 Jul;23(7):713-7. Drug Metab Dispos. 1995. PMID: 7587959

4

Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.

Pinna A, Agen C, Di Paolo A, Innocenti F, Nardini D, Danesi R, Del Tacca M. Pinna A, et al. Among authors: di paolo a. J Environ Pathol Toxicol Oncol. 1994;13(1):25-31. J Environ Pathol Toxicol Oncol. 1994. PMID: 7823290

5

Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.

Innocenti F, Danesi R, Di Paolo A, Loru B, Favre C, Nardi M, Bocci G, Nardini D, Macchia P, Del Tacca M. Innocenti F, et al. Among authors: di paolo a. Cancer Chemother Pharmacol. 1996;37(5):409-14. doi: 10.1007/s002800050405. Cancer Chemother Pharmacol. 1996. PMID: 8599862

6

Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines.

di Paolo A, Bocci G, Innocenti F, Agen C, Nardini D, Danesi R, del Tacca M. di Paolo A, et al. Pharmacol Res. 1995 Sep;32(3):135-9. doi: 10.1016/s1043-6618(05)80006-4. Pharmacol Res. 1995. PMID: 8745343

7

Chronic administration of suramin induces neurotoxicity in rats.

Di Paolo A, Danesi R, Innocenti F, Bocci G, Nardini D, Fogli S, Pollina L, Rossi B, Del Tacca M. Di Paolo A, et al. J Neurol Sci. 1997 Nov 25;152(2):125-31. doi: 10.1016/s0022-510x(97)00185-8. J Neurol Sci. 1997. PMID: 9415531

8

Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo.

Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M. Bocci G, et al. Among authors: di paolo a. Cancer Chemother Pharmacol. 1999;43(3):205-12. doi: 10.1007/s002800050885. Cancer Chemother Pharmacol. 1999. PMID: 9923550

9

Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.

Innocenti F, Danesi R, Bocci G, Fogli S, Di Paolo A, Del Tacca M. Innocenti F, et al. Among authors: di paolo a. Cancer Chemother Pharmacol. 1999;43(2):133-40. doi: 10.1007/s002800050873. Cancer Chemother Pharmacol. 1999. PMID: 9923818

10

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.

Fogli S, Danesi R, Innocenti F, Di Paolo A, Bocci G, Barbara C, Del Tacca M. Fogli S, et al. Among authors: di paolo a. Ther Drug Monit. 1999 Jun;21(3):367-75. doi: 10.1097/00007691-199906000-00022. Ther Drug Monit. 1999. PMID: 10365655 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters